GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of Covid-19 Vaccine Booster in Patients With Chronic Lymphocytic Leukemia
GeoVax宣佈COVID-19疫苗增強劑在慢性淋巴細胞白血病患者中的2期臨床試驗積極中期數據回顧
GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of Covid-19 Vaccine Booster in Patients With Chronic Lymphocytic Leukemia
GeoVax宣佈COVID-19疫苗增強劑在慢性淋巴細胞白血病患者中的2期臨床試驗積極中期數據回顧
譯文內容由第三人軟體翻譯。